Old Web
English
Sign In
Acemap
>
Paper
>
998 A phase II study of a novel taxane BAY 59-8862 in patients with aggressive refractory non-Hodgkin's lymphoma
998 A phase II study of a novel taxane BAY 59-8862 in patients with aggressive refractory non-Hodgkin's lymphoma
2003
R. Turner
A Delmer
T. Gentile
Pieter Sonneveld
D. Vesole
S. Turri
F. Barouki
S. Coppieters
Keywords:
Oncology
Pathology
Taxane
Phases of clinical research
Medicine
Hodgkin's lymphoma
Refractory Non-Hodgkin's Lymphoma
Internal medicine
Bay
in patient
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]